HealthCare Global Enterprises Ltd - 539787 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sunu ManuelDesignation :- Company Secretary and Compliance Officer HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Corrigendum to Postal Ballot Notice dated April 01, 2022 of HealthCare Global Enterprises Limited. HealthCare Global Enterprises Ltd - 539787 - Corrigendum To Postal Ballot Notice Dated April 01, 2022
Corrigendum to postal ballot notice dated April 01, 2022 HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Postal Ballot Notice dated April 01, 2022 of HealthCare Global Enterprises Limited ('the Company'). HealthCare Global Enterprises Ltd - 539787 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice (only through the remote e-voting process) for seeking members' approval for the agenda included therein. HealthCare Global Enterprises Ltd - 539787 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate of the Company. HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of unaudited financial results of HealthCare Global Enterprises Limited ('the Company') for the quarter and nine months ended December 31, 2021. HealthCare Global Enterprises Ltd - 539787 - Compliances- Statement Of Deviation For The Quarter Ended Dec 31, 2021
Statement of deviation or variation under Regulation 32 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as on December 31, 2021, pursuant to the preferential allotment of equity shares upon exercise of warrants convertible into equity shares of the Company, approved by the Board on December 06, 2021 and December 08, 2021 HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Directors on the Board of HealthCare Global Enterprises Limited ('the Company') on February 10, 2022 Q3FY22 Quarterly Result Announced for Healthcare Global Enterprises Ltd.
Healthcare Facilities Healthcare Global Enterprises declares Q3FY22 result: Q3’22 Revenue grew by 30.7% YoY HCG centers grew by 30.8 % Milann centers grew by 28.5 % Revenue from Vaccination is 43Mn, was 250 Mn in Q2’22 International business yet to return to its BAU level Q3’22 Operating EBITDA Existing centers : INR 566 Mn (20.6% margin vs 18.2% margin in Q3-FY21) New centers : INR 52 Mn (vs. loss of INR (21) Mn in Q3-FY21) Contribution from Vaccination is 12Mn, was 58.3 Mn in Q2’22 Q3’22 Proforma PAT : INR 12 Mn is after adjusting below and tax implications there of; Impairment of NCR Project INR 472 Mn Exceptional gain of INR 19 Mn arising out of Suchirayu acquisition One time project fee of Q3’22 INR 20 Mn YTD-FY22 Revenue grew by 44.4 % YoY HCG centers: +44.0 % Milann centers: +53.1 % YTD-FY22 Operating EBITDA Existing centers : INR 1,698 Mn (21.3% margin vs 17.6% margin in YTD-FY21) New centers : INR 51 Mn (vs. loss of INR (111) Mn in YTDFY21) YTD’22 Proforma PAT: INR -80 Mn is after adjusting below and tax implications there of; Impairment of NCR Project INR 472 Mn Exceptional gain of INR 1419 Mn arising out of Strand and Suchirayu acquisition Onetime project fee of Q3’22 INR 20 Mn Result PDF